drugset / Trial / NCT02218671

Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers

NCT02218671

Phase 1 Completed 10 enrolled Boehringer Ingelheim
CrossoverOpen-labelTreatment

Summary

Evaluation whether Brotizolam is absorbed through the mucous membrane of oral cavity when WE 941 OD tablets are administered in Japanese healthy male volunteers.

Timeline

Start
2000-03
Primary completion
2000-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Brotizolam Small molecule Oral

Indications

No indication recorded.